ICER issues affordability and access alert for tardive dyskinesia drugs

The Institute for Clinical and Economic Review issued an affordability and access alert for tardive dyskinesia drugs Ingrezza valbenazine (MT-5199, NBI-98854) and Austedo

Read the full 231 word article

User Sign In